<DOC>
	<DOCNO>NCT03035201</DOCNO>
	<brief_summary>The parent trial ( COcoa Supplement Multivitamin Outcomes Study , COSMOS ; NCT02422745 ) randomize clinical trial cocoa extract supplement ( contain total 600 mg/d flavanols , include 80 mg. ( - ) -epicatechins ) , standard multivitamin supplement reduce risk cardiovascular disease cancer among men age 60 year old woman age 65 year old . A cognitive ancillary study ( COSMOS-Mind ) conduct among men woman , 65 year old , enrol COSMOS examine whether cocoa extract supplement multivitamin supplement improve cognitive function reduces risk cognitive impairment , include AD related type dementia .</brief_summary>
	<brief_title>COcoa Supplement Multivitamin Outcomes Study Mind</brief_title>
	<detailed_description>Identifying safe , affordable , well-tolerated intervention prevents cognitive decline old adult critical public health importance . There compel evidence basic science , small clinical study cocoa flavanols may protect cognitive function old adult reduce risk Alzheimer 's disease ( AD ) relate dementia . Thus , intervention could important downstream benefit health care utilization cost , caregiver burden , overall quality life old adult . Cocoa flavanol effect cognition , however , need assess definitive clinical trial . The parent trial ( COSMOS ) enroll 18,000 woman men nationwide , drawn Women 's Health Initiative ( WHI ) participant cohort VITamin D OmegA-3 TriaL ( VITAL ) non-randomized respondent cohort , conduct primarily mail ass whether high-potency cocoa flavanol extract multivitamin - alone combination - reduce risk cardiovascular disease cancer 3 year follow-up . Once participant enrol COSMOS , study team Brigham Women 's Hospital provide contact information parent trial outcomes COSMOS-Mind participant Wake Forest team use secure web-based data transfer system . This seamless exchange information sit permit timely accounting ensure target demographic enrollment achieve ( e.g . gender , age , race , ethnicity ) . COSMOS-Mind administer telephone cognitive assessment participant enrollment ( baseline ) , annually 3 year follow-up train certified staff Wake Forest COSMOS-Mind team .</detailed_description>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<criteria>Participants COSMOS ( NCT02422745 ) meet follow criterion eligible participate ancillary study : Inclusion Criteria 1 . Men woman 65 year old . 2 . Willingness participate . 3 . Ability answer question phone . Exclusion Criteria 1 . Participants coenrolled WHI Memory Study . 2 . Participants insulindependent diabetes . 3 . Participants unable complete baseline cognitive assessment .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Memory</keyword>
	<keyword>Mild Cognitive Impairment</keyword>
	<keyword>Alzheimer 's Disease</keyword>
	<keyword>Cognition</keyword>
</DOC>